VINCERE VITAE
Compound Intelligence
Retatrutide
Latest research activity, publications, abstracts, and scientific signals for Retatrutide.
Total Papers
12
Primary Source
PubMed
Status
Tracking
Intelligence Summary
Retatrutide currently has 12 tracked PubMed research entries in Research Radar. The latest tracked publication is "Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure.".
Journals
12
Authors
65
Latest Publication
2026 Jun 6
Trend Score
100
Research Activity
Research activity detected through PubMed ingestion.
Source Quality
Current intelligence is based on PubMed metadata and abstracts only.
Status
Tracking
Latest Retatrutide Research
PubMed
Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure.
Current obesity reports · 2026 Jun 6
PubMed
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
Lancet (London, England) · 2026 Jun 6
PubMed
Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050.
Clinical nutrition ESPEN · 2026 Jun
PubMed
Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies.
Metabolism open · 2026 Jun
PubMed
GIPR:GCGR co-agonism restores normal weight in obese rodents.
Molecular metabolism · 2026 Jun
PubMed
Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.
Aesthetic surgery journal · 2026 Jun 1
PubMed
A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
Organic letters · 2026 Jun 1
PubMed
Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026 May 29
PubMed
Beyond weight loss: multisystem benefits of obesity medications.
The lancet. Diabetes & endocrinology · 2026 May 28
PubMed
Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.
European journal of clinical pharmacology · 2026 May 22
PubMed
Diabetes Mellitus and Stroke: Pathophysiological Connections and Therapeutic Potential of GLP-1 and GLP-1/GIP Receptor Agonists.
Pharmaceutics · 2026 May 19
PubMed
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.
Medicina (Kaunas, Lithuania) · 2026 May 18